Top Pharmacovigilance Outsourcing for US & EU Biopharma Sponsors
Top Pharmacovigilance Outsourcing for US & EU Biopharma Sponsors Bridging the gap between global scale and local regulatory precision. For US and EU-based sponsors, the regulatory landscape is more than a hurdle—it is a moving target. With the 2026 updates to EMA GVP modules and the FDA’s heightening focus on Post-Market Safety Surveillance, “checking the […]
Risk-Based Assessment for PV Audits for the US FDA, EMA and MHRA
🔎 Risk-Based Assessment for PV Audits and Vendor qualification (Due diligence): When & how to perform them? Most pharmacovigilance (PV) audit programs fail not because they are incomplete, but because they attempt to audit everything equally. In today’s complex regulatory environment, this approach no longer works. Regulators expect organisations to demonstrate risk awareness, prioritisation, and […]
Strategic Pharmacovigilance Consulting: GVP QMS, PSMF & AI Integration for Compliance
Beyond Outsourcing: Why Strategic Pharmacovigilance Consulting Outperforms Standard CRO Models In the rapidly evolving landscape of 2026, pharmaceutical, biotech, and even medical device companies face unprecedented pressure. Rising case volumes, complex global regulations, and the imperative for real-time safety insights demand a shift from reactive, transactional services to proactive, intelligent Strategic Pharmacovigilance Consulting. While […]
AI/ML in Pharmacovigilance Automation: Strategic Safety Database Integration
The Strategic Shift: AI/ML in Pharmacovigilance Automation In the current 2026 regulatory landscape, the implementation of AI/ML in Pharmacovigilance Automation has transitioned from a theoretical concept to a critical operational requirement. Pharmaceutical companies and CROs are facing an unprecedented surge in adverse event volumes, necessitating smarter, faster, and more scalable solutions. At GPLACO Solutions, […]
ICSR Compliance: Building Inspection-Ready Case Processing in Global Pharmacovigilance
ICSR compliance is the backbone of global pharmacovigilance and the most frequent source of regulatory findings during inspections. Health Authorities do not assess pharmacovigilance maturity by dashboards or promises — they assess it by how consistently, accurately, and timely Individual Case Safety Reports are processed and submitted. Across FDA, EMA, MHRA, and APAC authorities, ICSR […]
Pharmacovigilance Compliance for MAH and Sponsor – Pathway from SDEA to PSMF
Understanding Pharmacovigilance Compliance for MAH and Sponsors : The Global Pharmacovigilance strategy for US, UK, EU, TGA and APAC! Achieving full Pharmacovigilance Compliance is a top priority for every MAH and Sponsor navigating the pathway from SDEA to PSMF. As regulatory landscapes evolve globally, maintaining a robust safety system is not just a legal requirement […]
Global Pharmacovigilance Strategy, Safety Governance & Compliance – US, EU, UK & APAC
Mastering Your Global Pharmacovigilance Strategy and Safety Governance Developing a robust Global Pharmacovigilance Strategy is the cornerstone of any successful pharmaceutical expansion into international markets. As companies look to navigate the complex regulatory environments of the US, EU, UK, and APAC regions, the need for a unified approach to safety governance has never been […]
Pharmacovigilance Vendor Outsourcing : Mastering Due diligence and successful Vendor outsourcing:
Mastering Due diligence Strategic Pharmacovigilance Vendor Outsourcing When it comes to Pharmacovigilance Vendor Outsourcing, successful due diligence is the first step toward a compliant partnership. As pharma companies scale, outsourcing becomes necessary, but it introduces significant regulatory risk if not managed correctly. Key Steps in Due Diligence Before signing a contract for Pharmacovigilance Vendor Outsourcing, […]
ICSR Quality Management : Solving issues in Pharmacovigilance
Methods to identify errors; how to classify them and what should be the plan? Improving ICSR Quality Management in Safety Reporting Implementing a rigorous ICSR Quality Management system is the only way to ensure that Individual Case Safety Reports meet global regulatory standards. Quality issues in ICSRs can lead to “Request for Information” (RFI) letters […]
PSUR vs PBRER: Navigating Global Aggregate Safety Reporting
Understanding the Transition: PSUR vs PBRER In the world of aggregate safety reporting, the comparison of PSUR vs PBRER is a vital topic for any MAH. While the Periodic Safety Update Report (PSUR) was the traditional standard, the Periodic Benefit-Risk Evaluation Report (PBRER) has now become the international norm under ICH E2C (R2) guidelines. GPLACO […]